Really nice to see important data out. Been using dosing since presented at @ASCO 2019. Efficacy of Reduced-Intensity Chemotherapy Among Older and Frail Patients With Advanced Gastroesophageal... https://t.co/S5VcFu2Kbe via @JAMAOnc part of @JAMANetwork
ctDNA in UGI malignancies. It was a pleasure to contribute with this opinion paper alongside my mentor. Many thanks Dr @LizzySmyth1 for this opportunities and many others more!
https://t.co/4IvOujM3ej
DDF and CancerCare will jointly launch the first-ever helpline dedicated to #stomachcancer patients, their families, caregivers, and those who've lost loved ones to the disease. Read the press release at https://t.co/Yg4q1JnzEc.
#DebbiesDreamFoundation#CancerCare#PatientSupport
We have partnered with @StoCANcer to create a Bag It Bag that includes specific information about stomach cancer. You can order Hope In a Bag here: https://t.co/l3ndI80agt. #stomachcancer#fightthefear#cancer#hcsm
Really excellent review on intratumoral heterogeneity in @NatureMedicine . Important in CIN gastroesophageal cancers.
https://t.co/zVHA7wFSOu -- text
https://t.co/lQoxs0TVCr
Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer https://t.co/HkdBy4qQpp
Nice paper in @Gut_BMJ Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing https://t.co/GDFuImys8C
Nice #GI21@ASCO_pubs abstr from great Rad-Onc resident Daniel Kim showing Increased T-cell receptor repertoire diversity predicts better overall survival in GI Cancers, including #GEA. @TedHong9 @MGHCancerCenter @Mark_Cobbold https://t.co/8JH4Ida4ZA
Preprint. Results and molecular correlates from neoadjuvant induction FOLFIRINOX followed by chemoradiation and surgery for gastroesophageal adenocarcinomas. @TedHong9 @MGHCancerCenter Pilot data for #ctDNA in neoadj @pashtoonkasi https://t.co/xjjVSYn7qg
More data for this targeted population. @Gut_BMJ EGFR amplification and outcome in REAL3 (EOX +/- Panitumumab) for advanced gastro-oesophageal cancers. @LizzySmyth1@DocCatenacci@SteveMaronMD https://t.co/IYODwEG6Iy
Still time to register for this great virtual #stomach and #esophageal research meeting led by @targetcancer and @BassLab_DFCI Link below. Always a great lineup @OncoAlert